Whole Exome Sequencing Market Trends, Emerging Growth, Competitor Analysis And Industry Overview
The global whole exome sequencing market is growing at a
rapid pace. Market growth attributes to the rising usage of exome in the
identification and determination of genetic variants, increasing the chances of
diseases such as Miller syndrome and Alzheimer’s. Besides, the decreasing cost
of sequencing and the use of whole-exome sequencing technology for varied
applications, drive the market growth.
Moreover, increasing product launches and regulatory
approvals escalate the growth of the market. According to Market Research
Future (MRFR), the global Whole
Exome Sequencing Market is expected
to reach USD 2,696.03 MN by 2025, growing at 19.80% CAGR throughout the forecast
period (2019 – 2025). Advantages of whole-exome sequencing procedures increase
the market size.
Major Players
Players leading the global whole exome sequencing
market include BGI (China), Illumina Inc. (US), Eurofins Scientific (Belgium),
Agilent Technologies, Inc. (US), Thermo Fisher Scientific (US), F. Hoffmann-La
Roche Ltd (Switzerland), Ambry Genetics (US), GENEWIZ (US), Macrogen, Inc.
(South Korea), and Integragen SA (France), among others.
Whole Exome Sequencing Market - Segments
The report is segmented into five dynamics.
By Product: Kits (DNA Fragmentation, End Repair,
A-Tailing, And Size Selection Kits, Library Preparation, Target Enrichment,
others), Sequencer, Services {Sequencing Services, Data Analysis
(Bioinformatics), others}, and others.
By Technology: Sequencing by Synthesis (SBS), ION
Semiconductor Sequencing, and others.
By Application: Diagnostics {Cancer Diagnostics,
Monogenic (Mendelian) Disorders, Monogenic Types of Diabetes, Movement
Disorders, HIV, others}, Drug Discovery & Development, Agriculture &
Animal Research, and others.
By End User: Research Centers & Government Institutes,
Hospitals & Diagnostics Centers, Pharmaceutical & Biotechnology
Companies, and others.
By Regions:
North America, Europe, APAC, and Rest of the World.
Whole Exome Sequencing Market - Regional Analysis
North America dominates in the global whole
exome sequencing price. The largest market share attributes to the high
prevalence rate of cancer & other chronic disorders and high healthcare
expenditure. Besides, favorable government initiatives for the development and
adoption of whole-exome sequencing technologies drive the growth of the
regional market. Moreover, efforts of private organizations aiming to produce
genome data for researchers and precision medicine research platforms foster
regional market growth.
Additionally, the presence of global players and encouraging
research and development in healthcare boost regional market growth. Other
factors, such as increased uptake of advanced technologies and high healthcare
expenditures, substantiate the growth of the regional market. The US, backed by
the rising demands for whole exome sequencing procedures, accounts for the
significant growth contributor to the regional market.
Europe stands second in the global whole exome sequencing
market. The market is driven by rising cancer cases and increasing programs to
promote the adoption of genome sequencing. Moreover, recent advancements in the
technology and the augmenting uptake of the advanced technology in the region
foster the regional market.
Additionally, the presence of a well-developed medical device
industry and rising healthcare expenditure facilitates regional market growth.
Also, factors such as the rising support and funding from public & private
sectors for research & development fuel the market growth in the region.
The Asia Pacific whole exome sequencing market is emerging
as the rapidly growing market, globally. Factors such as the increasing
technological advancements, per capita income, and government initiatives to
improve healthcare quality, drive the regional market growth.
Furthermore, the growing patient pool and the older
population in China, India, and Australia have enabled the regional market to
grow promisingly. Also, the rising demand for these whole exome sequencing
procedures and the increasing adoption of advanced techniques in these
procedures drive the regional market growth.
Global Whole Exome Sequencing Market - Competitive Analysis
Highly competitive, the whole exome sequencing market
appears fragmented due to the presence of many well-established players. These
players adopt strategic approaches such as mergers & acquisitions,
collaboration, expansion, and technology launch to strengthen their market
positions.
They invest substantially in developing new technologies and
upgrade their existing sequencing techniques. Also, they make substantial
investments to expand their global footprints.
Industry/Innovations/Related News:
July 22, 2020 ---- Swift Biosciences, Inc.(the US), a
leader in the commercialization of DNA & RNA library preparation kits for
Next-Generation Sequencing (NGS), announced its partnership with Otogenetics
Corporation, a high throughput NGS clinical lab to distribute its Swift 2S®
Turbo DNA Library Kits. Otogenetics offers prenatal testing, hereditary cancer
risk assessment, deafness testing, rare diseases, clinical exome, and other
tests for personalized medicine & clinical trials.
The collaboration would help Otogenetics ramp its hereditary
disease & personalized medicine service areas and initiatives by
supercharging its clinical whole-exome sequencing (WES) offerings. The
sequencing of exome allows researchers and clinicians to obtain decision-making
data for genetic variants responsible for Mendelian diseases.
About US:
Market Research Future (MRFR) enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private
Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment